TY  - JOUR
T1  - Commentary on an article by Rick Delamarter, MD, et al.: “Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of the ProDisc-L Total Disc Replacement Compared with Circumferential Arthrodesis for the Treatment of Two-Level Degenerative Lumbar Disc Disease. Results at Twenty-four Months”
AU  - Schoenfeld, Andrew J.
Y1  - 2011/04/20
N1  - 10.2106/JBJS.J.01847
JO  - The Journal of Bone & Joint Surgery
SP  - e41 1
EP  - 2
VL  - 93
IS  - 8
N2  - 
For nearly as long as spinal arthrodesis has been used to treat lumbar spine disorders, concerns have been raised regarding the long-term biomechanical and anatomic ramifications of successful fusion, particularly adjacent-segment disc degeneration and loss of lumbar range of motion. In many ways, the specter of adjacent-segment disc degeneration has been most concerning as it can lead to a deterioration in function that was gained following the initial procedure as well as to symptoms that may require further surgery. As a result, new surgical devices and procedures are being developed with the intention of treating lumbar degenerative conditions while maintaining near-normal biomechanical and anatomic parameters. Without question, the total disc replacement is one such "motion-sparing" device that has received substantial attention within the spine surgery community.

SN  - 0021-9355
M3  - doi: 10.2106/JBJS.J.01847
UR  - http://dx.doi.org/10.2106/JBJS.J.01847
ER  -